Factor V Leiden mutation in cerebral venous thrombosis

Stroke

Volumn 27, Issue 10, 1996, Pages 1721-1723

  Zuber, Mathieu ^a   Toulon, Pierre ^b   Marnet, Laurence ^b   Mas, Jean Louis ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b Hôpital Cochin ^*  (France)

Author keywords

coagulation; genetics; hereditary disease; sinus thrombosis

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5; ORAL CONTRACEPTIVE AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CASE CONTROL STUDY; CAVERNOUS SINUS THROMBOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; GENETIC DISORDER; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0029762332     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.10.1721     Document Type: Article

References (22)

1. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90: 1004-1008.
2. Koster T, Rosendaal FR, de Ronde H, Briet E. Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993; 342:1503-1506.
3. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994;330:517-522.
4. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912-917.
5. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High-risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85:1504-1508.
6. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
7. Zoller B, Dahlback B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 1994;343:1536-1538.
8. Simioni P, de Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A. Ischemic stroke in young patients with activated protein C resistance: a report of three cases belonging to three different kindreds. Stroke. 1995;26:885-890.
9. Bachmeyer C, Toulon P, Zuber M, Dhote R, Mas JL, Christoforov B. Ischemic stroke and activated protein C resistance. JAMA. 1995; 274:1266. Abstract.
10. Kontula K, Ylikorkala A, Micttinen H, Vuorio A, Kauppinen-Mäkelin R, Hämäläinen L, Palomäki H, Kaste M. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost. 1995;73:558-560.
11. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992;10:87-111.
12. Yasargil MG, Damur M. Thrombosis of the cerebral veins and dural sinuses. In: Newton TH, Potts DG, eds. Radiology of the Skull and Brain: Angiographv. Book 4. St Louis, Mo: CV Mosby Co; 1974: 2375-2400.
13. Mas JL, Meder JF, Meary E, Bousser MG. Magnetic resonance imaging in lateral sinus hypoplasia and thrombosis. Stroke. 1990;21: 1350-1356.
14. Mas JL, Meder JF, Meary E. Dural sinus thrombosis: long-term follow-up by magnetic resonance imaging. Cerebrovasc Dis. 1992;2: 137-144.
15. Gharavi AE, Harris EN, Asherson RA, HughesGRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis. 1987;46:1-6.
16. Working Group on Hemostasis of the Société Française de Biologie Clinique. Comparison of a standardized procedure with current laboratory practices for the detection of lupus anticoagulant in France. Thromb Haemost. 1993;70:781-786.
17. Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the method for the factor V Arg506→Gln mutation. Blood Coag Fibrinol. 1995;6:245-248.
18. Martinelli I, Landi G, Merati G, Cella E, Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost. 1996;75:393-394.
19. Greaves M. Coagulation abnormalities and cerebral infarction. J Neurol Neurosurg Psychiatry. 1993;56:433-439.
20. Schafer AI. Hypercoagulable states: molecular genetics to clinical practice. Lancet. 1994;344:1739-1742.
21. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet. 1994; 344:1453-1457.
22. Baker R, Thom J, van Bockxmeer F. Diagnosis of activated protein C resistance (factor V Leiden). Lancet. 1994;344:1162. Abstract.